- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia in New Zealand
Total 800 results
-
University of RochesterNational Cancer Institute (NCI)CompletedProstate Cancer | OsteoporosisUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Thomas Jefferson UniversityProstate Cancer FoundationActive, not recruitingBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
GlaxoSmithKlineCompletedOveractive BladderAustralia
-
Taipei Medical University Shuang Ho HospitalCompletedLower Urinary Tract Symptoms | Overactive Bladder SyndromeTaiwan
-
University of Michigan Rogel Cancer CenterMemorial Sloan Kettering Cancer Center; University of California, San FranciscoActive, not recruitingSolid Tumor | Metastatic Cancer | Metastatic Castration Resistant Prostate CancerUnited States
-
University of RochesterRecruitingProstate Cancer | HDRUnited States
-
University of RochesterCompletedUrinary IncontinenceUnited States
-
University of MinnesotaUniversity of Pennsylvania; Washington University School of Medicine; University... and other collaboratorsEnrolling by invitation
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, Czech Republic, France, Russian Federation, United Kingdom, Germany, China, Hungary, Poland, Finland, Netherlands, Mexico, Hong Kong, Australia, Belgium, Canada, Denmark, Portugal, South Africa, Korea... and more
-
GlaxoSmithKlineCompletedNeoplasms, ProstateFrance, Germany, Spain, United States, Netherlands, Canada, United Kingdom, Finland, Chile, Sweden, Argentina, Greece
-
Urovant Sciences GmbHIon Channel InnovationsCompletedOveractive BladderUnited States
-
Curium US LLCCompletedMetastasis From Malignant Tumor of Prostate (Disorder)United States
-
Winthrop University HospitalCompleted
-
Roswell Park Cancer InstituteWithdrawnCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the Bone | PSA...United States
-
Roswell Park Cancer InstituteAbbVieCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Castration Levels of Testosterone | Prostate Carcinoma...United States
-
FibroGenAstraZenecaWithdrawnAnemia Associated With Chronic Kidney DiseaseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
University of MinnesotaUniversity of Pennsylvania; Washington University School of Medicine; University... and other collaboratorsCompletedLower Urinary Tract SymptomsUnited States
-
Curium US LLCRecruitingProstate Cancer | Prostate Adenocarcinoma | Biochemical Recurrence of Malignant Neoplasm of ProstateUnited States
-
Curium US LLCActive, not recruitingMetastasis From Malignant Tumor of ProstateUnited States, France, Spain, Italy
-
Far Eastern Memorial HospitalCompletedLower Urinary Tract Symptoms | Pelvic Organ ProlapseTaiwan
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
Northwell HealthMedtronics, Inc.CompletedDetrusor OveractivityUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; SWOG Cancer Research...CompletedProstate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
MedtronicNeuroCompletedOveractive BladderUnited States
-
Eisai Inc.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
En Chu Kong HospitalCompleted
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
Far Eastern Memorial HospitalRecruiting
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
Myrexis Inc.UnknownProstate CancerUnited States
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
Ferring PharmaceuticalsCompleted
-
Medstar Health Research InstituteColumbia University; University of Michigan; University of New Mexico; Methodist...Terminated
-
Boehringer IngelheimCompletedLower Urinary Tract SymptomsUnited States
-
Atlantic Health SystemCompletedStress Urinary IncontinenceUnited States
-
Ferring PharmaceuticalsCompletedNocturiaUnited States, Belgium, Czechia, Hungary, Poland, Canada, Germany
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalWithdrawnOveractive Bladder SyndromeTaiwan
-
GlaxoSmithKlineCompletedOveractive BladderGermany, Taiwan, Netherlands, Spain, Australia, Korea, Republic of, Latvia, Argentina, Slovenia, Finland, France, South Africa, Poland, New Zealand
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States